AstraZeneca profits fall despite Covid sales boost
ASTRAZENECA fell $265million into the red last year, due mainly to the cost of developing its Covid-19 treatments.
ASTRAZENECA fell $265million into the red last year, due mainly to the cost of developing its Covid-19 treatments.